Oct4-Induced Pluripotency in Adult Neural Stem Cells  by Kim, Jeong Beom et al.
Oct4-Induced Pluripotency
in Adult Neural Stem Cells
Jeong Beom Kim,1 Vittorio Sebastiano,1 Guangming Wu,1 Marcos J. Arau´zo-Bravo,1 Philipp Sasse,2 Luca Gentile,1
Kinarm Ko,1 David Ruau,3 Mathias Ehrich,4 Dirk van den Boom,4 Johann Meyer,5 Karin Hu¨bner,1 Christof Bernemann,1
Claudia Ortmeier,1 Martin Zenke,3 Bernd K. Fleischmann,2 Holm Zaehres,1 and Hans R. Scho¨ler1,*
1Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Ro¨ntgenstrasse 20, 48149 Mu¨nster,
NRW, Germany
2Institute of Physiology I, Life & Brain Center, University of Bonn, 53105 Bonn, NRW, Germany
3Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, Pauwelsstrasse 30,
52074 Aachen, NRW, Germany
4SEQUENOM Inc., 3595 John Hopkins Court, San Diego, CA 92121, USA
5Hannover Medical School, Department of Experimental Hematology, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany
*Correspondence: office@mpi-muenster.mpg.de
DOI 10.1016/j.cell.2009.01.023SUMMARY
The four transcription factors Oct4, Sox2, Klf4, and
c-Myc can induce pluripotency in mouse and human
fibroblasts. We previously described direct reprog-
ramming of adult mouse neural stem cells (NSCs)
by Oct4 and either Klf4 or c-Myc. NSCs endoge-
nously express Sox2, c-Myc, and Klf4 as well as
several intermediate reprogramming markers. Here
we report that exogenous expression of the germ-
line-specific transcription factor Oct4 is sufficient to
generate pluripotent stem cells from adult mouse
NSCs. These one-factor induced pluripotent stem
cells (1F iPS) are similar to embryonic stem cells
in vitro and in vivo. Not only can these cells can be
efficiently differentiated into NSCs, cardiomyocytes,
and germ cells in vitro, but they are also capable of
teratoma formation and germline transmission
in vivo. Our results demonstrate that Oct4 is required
and sufficient to directly reprogram NSCs to pluripo-
tency.
INTRODUCTION
For centuries, embryologists have been intrigued by the
distinction between germ cells (GCs) and soma (McLaren,
1981; Pesce et al., 1998; Weismann, 1892). Any attempt to
establish such a distinction eventually needs to address the
question, which genetic program specifically defines the plurip-
otent founder population that gives rise to all cell lineages of
the body as well as the GC lineage and ensures the flow of
genetic information from one generation to the next. One way
of establishing a distinction between germline and soma is to
determine the regulatory factors expressed in both the pluripo-
tent cells and stem cells of the GC lineage but not in somatic
cells. Interestingly, the genetic programs of pluripotent cellsand GC stem cells exhibit intriguing similarities. Several key
factors required for pluripotency are also expressed in primor-
dial germ and spermatogonial stem cells. However, when it
comes to comparing them to the repertoire of factors in the
soma, very few actually stand out. Based on its expression
profile, the transcription factor Oct4 was from the beginning
considered to be a key regulator during mouse embryogenesis.
Oct4 is expressed in the pluripotent cells of an embryo and in
cell lines derived thereof, as well as in the GC lineage. Embry-
onic stem cells (ESCs) derived from preimplantation embryos
can easily integrate into the germline. This has previously
been shown for mouse preimplantation embryos (Boiani and
Scho¨ler, 2005). In contrast, Oct4 is downregulated in the three
somatic lineages, but only during gametogenesis around the
initiation of male and female meiosis (Pesce et al., 1998).
Oct4 is re-expressed in unfertilized oocytes after birth and
Oct4 protein can be detected until the final stages of oocyte
maturation.
Loss of Oct4 function early in development causes cells of
the preimplantation embryo to acquire a trophectodermal fate
(Nichols et al., 1998), whereas loss in the GC lineage leads to
apoptosis of primordial germ cells (PGCs) (Kehler et al.,
2004). These studies of the developing embryo were comple-
mented by studies of ESCs in which the Oct4 function was
abolished (Niwa et al., 2000). ESCs are especially interesting
in this context, as they are derived from the inner cell mass
of the blastocyst and thus represent a developmental stage
following the establishment of the pluripotent founder popula-
tion. While loss of Oct4 function results in differentiation into
trophectodermal cells, overexpression of Oct4 in ESC leads
to differentiation along the mesodermal and primitive endo-
dermal lineages.
The early developmental phenotype suggests that Oct4 is
part of a regulatory system that maintains pluripotency.
A precise level of Oct4 is required to maintain pluripotency in
ES cells, which is in agreement with this hypothesis. The fact
that stem cells of the GC lineage are unipotent despite express-
ing Oct4, albeit at lower levels, shows that its mere presenceCell 136, 411–419, February 6, 2009 ª2009 Elsevier Inc. 411
does not result in pluripotency. However, we hypothesize that
the presence of Oct4 augments the induction of pluripotency.
As shown for PGCs, Oct4-expressing cells can give rise to
pluripotent cells (termed embryonic germ cells) when cultured
in a simple cocktail of three growth factors (Matsui et al.,
1992; Resnick et al., 1992).
Recently, Yamanaka and colleagues have shown that the
genetic program of somatic cells can be induced to acquire
pluripotency by overexpression of specific transcription factors.
Initially, generation of pluripotent cells was achieved by ectopic
expression of four factors (Oct4, Sox2, Klf4, and c-Myc) from
mouse and human somatic cells (Lowry et al., 2008; Maherali
et al., 2007; Meissner et al., 2007; Okita et al., 2007, 2008;
Park et al., 2008; Stadtfeld et al., 2008; Takahashi et al., 2007;
Takahashi and Yamanaka, 2006; Wernig et al., 2007; Yu et al.,
2007). These ESC-like induced pluripotent stem (iPS) cells
have characteristics similar to ESCs.
The molecular mechanisms underlying reprogramming are still
far from being completely understood, which is largely due to
several variables (number of exogenous factors required, hetero-
geneity of reprogramming target cells) within the system. We
attempted to simplify this scenario by choosing NSCs as a cell
model for reprogramming with different combinations of tran-
scription factors (Kim et al., 2008). The combination of the
specific factors needed to obtain iPS cells varies, though Oct4
can apparently not be replaced by other factors. Recently, we
demonstrated that Oct4 and Klf4 are sufficient to induce
pluripotency in NSCs (Kim et al., 2008). By omitting Klf4, we
have established conditions that demonstrate that Oct4 is not
only essential but also sufficient to induce pluripotency in
NSCs. Our study shows for the first time that just one transcrip-
tion factor can convert somatic cells into pluripotent cells, which
can differentiate into derivatives of all three germ layers and into
functional GCs.
RESULTS
Neural Stem Cells Endogenously Express AP
and SSEA-1
In our previous study we utilized Oct4-GFP expression as
a reprogramming marker, and we observed that the time
required for reprogramming was affected by both the number
(4, 3, or 2) and the composition of the pluripotency-inducing
factors (Oct4, Sox2, Klf4, and c-Myc) (Kim et al., 2008). Other
studies examined the reprogramming timing in more detail by
reprogramming mouse fibroblasts using the doxycycline (dox)-
inducible system (Brambrink et al., 2008; Wernig et al., 2007).
These studies demonstrated the sequential expression of
marker genes, such as alkaline phosphatase (AP), stage-
specific embryonic antigen-1 (SSEA-1), and Oct4 or Nanog,
during the reprogramming process. Thus, expression of
SSEA-1 represents an intermediate stage, which precedes
expression of Oct4 or Nanog and which in turn is required before
a cell can be fully reprogrammed to a pluripotent state. Interest-
ingly, NSCs endogenously express SSEA-1 and also show AP
activity (Figure S1 available online) (Capela and Temple, 2002;
Peh et al., 2008). Following infection of NSCs with the four
factors (4F), the cells give rise to GFP+ cells on day 4 and412 Cell 136, 411–419, February 6, 2009 ª2009 Elsevier Inc.GFP+ colonies on day 7 (Kim et al., 2008). In contrast to
NSCs, GFP+ cells are first observed in MEFs on day 7 post-
infection of 4F (Okita et al., 2007). We therefore considered
the possibility that NSCs might represent a more advanced
stage in the reprogramming process and that terminally
differentiated cells have to go through a stage like this in order
to subsequently acquire a pluripotent state. In this scenario,
expression of AP and SSEA-1 in NSCs marks a quasi-
intermediate state, during which NSCs are reprogrammed
earlier and more efficiently than MEFs.
iPS Cells Generated from Adult Neural Stem Cells with
Transduction of Oct4 at the Molecular Level Are Similar
to Embryonic Stem Cells
In our previous study, NSCs could be reprogrammed with three-
factor (3F) and two-factor (2F) combinations (Kim et al., 2008).
Moreover, in the 2F combinations c-Myc and Klf4 could be
replaced with one another, although c-Myc was less efficient
than Klf4 in inducing the formation of GFP+ colonies (3–4 weeks,
instead of 2–3 weeks). Next, we sought to define conditions in
which NSCs can be reprogrammed by transduction of Oct4
alone. As time has been an issue when using various factor
combinations, we prolonged the culturing of Oct4-infected cells.
In the current study, we succeeded in generating three one-
factor (1F) iPS clones (clones 2, 3, and 4) from five GFP+ colonies
of Oct4-infected NSCs within 4–5 weeks in culture (Figure 1A).
The iPS cells expressed Oct4-GFP, SSEA-1, and AP and were
morphologically indistinguishable from mouse ESCs under
mouse ESC culture conditions (Figure 1B). The estimated
reprogramming efficiency for the one-factor approach can be
calculated as 0.014%, which is 10-fold lower than our two-factor
approach (Kim et al., 2008) and similar to reprogramming MEFs
with four factors (Okita et al., 2007).
We next characterized the 1F iPS at the molecular level. All
three clones expressed typical ESC marker genes (Figure 2A)
and the endogenous genes Oct4, Sox2, c-Myc, and Klf4, similar
to mouse ESCs (Figure 2B). The Oct4 transgene was completely
silenced after passage 5 (Figure S2). To determine the number of
viral Oct4 transgene integrations, we performed Southern blot
analysis on ESCs, 1F, 2F, and 4F iPS cells. The 1F iPS clones dis-
played 2 and 5 integrations (Figure S3A), while 2F or 4F iPS cell
displayed 7 integrations (Figure S3B). We performed Southern
blot analysis from three independent subclones of clone 2
(Figure S3B). The same integration pattern confirmed that no
crosscontamination occurred during the expansion of these
subclones. Thus, 1F iPS could be generated with less viral inte-
grations of the Oct4 transgene than 2F or 4F iPS cells. We also
confirmed integration of the Oct4 transgene by polymerase
chain reaction (PCR): all 1F iPS clones contained only the Oct4
transgene (Figure S4).
We next performed DNA methylation analysis to assess the
epigenetic status of the Oct4, Sox2, and Nanog promoters with
DNA isolated from ESCs, NSCs, 2F iPS cells, and 1F iPS clones
(Figure 2C). Sox2 promoter maintains the demethylated status in
all populations (ESCs: 10%, 2F iPS: 3%, 1F iPS: 5%, NSCs: 3%,
NSC 1F: 3%). Oct4 and Nanog promoters were highly demethy-
lated in ESCs (13%, 9%) and 2F iPS cells (13%, 8%) and retained
partial methylation in 1F iPS (31%, 27%). 1F iPS-derived NSCs
(NSC 1F) were highly methylated at those loci (68%, 85%),
similar to donor NSCs (70%, 80%). The methylation data
suggest slight differences between 1F iPS and ESCs. Scatter
plots of the global gene expression profiles obtained from
cDNA microarrays demonstrated that 1F iPS exhibit a distribution
pattern of gene expression comparable to ESCs, hence
completely different from NSCs (Figures 2D and 2E).
1F iPS Can Be Differentiated into Three Germ Layers
including NSCs, Cardiomyocytes, and GCs In Vitro
To investigate the developmental potential of 1F iPS in vitro, we
determined whether 1F iPS could differentiate into three germ
layers by embryonic body (EB) differentiation. EBs derived
from all three 1F iPS clones expressed markers of the three
germ layers including GATA-4 (endoderm), Brachyury (meso-
derm), and MAP2 (ectoderm) as determined by RT-PCR
(Figure S5A).
Figure 1. Generation of One-Factor iPS Cells from Adult NSCs by
Retroviral Transduction of Oct4
(A) Morphology and Oct4 promoter-driven GFP (Oct4-GFP) expression (inset)
in reprogrammed one-factor (1F) iPS without feeders (passage 0) on day 35
post-infection and 1F iPS (clone 2) grown on feeders (passage 1). Scale
bars, 100 mm.
(B) Phase contrast image showing ESC-like morphology (upper left) of 1F iPS
(clone 2) on feeders. Colonies express Oct4-GFP (green, upper right) and
stained positive for SSEA-1 (red, lower left) and for AP (lower right). Abbrevia-
tions: SSEA-1, stage-specific embryonic antigen-1; AP, alkaline phosphatase.
Scale bars, 200 mm.Next, we attempted to determine whether 1F iPS could differ-
entiate into lineage-committed populations of NSCs, cardiomyo-
cytes, or PGCs. We derived NSCs from 1F iPS in serum-free
adherent monolayer cultures according to a published protocol
(Ying et al., 2003). Interestingly, these NSC 1F were very similar
to the donor NSCs. NSC 1F can maintain their self-renewal
capacity, even after repeated passaging. RT-PCR analysis
revealed NSC-specific gene expression similar to donor NSCs
but no expression of pluripotency markers such as Oct4 or
Nanog (Figure 3A). NSC 1F appeared highly homogenous, and
immunocytochemical staining confirmed the uniform expression
of the NSC marker Nestin (Figure 3B). Moreover, these NSC 1F
were capable of differentiating into neurons, oligodendrocytes,
and astrocytes after prolonged time in culture (passage 20)
(Figures 3B and S6). The modal chromosome number of 40
was maintained throughout reprogramming and derivation of
NSCs (Figure 3C). Our results demonstrate that 1F iPS can be
differentiated efficiently into multipotent NSCs that have self-
renewing capacity with global gene expression profiles similar
to donor NSCs (Figure 3D).
During EB differentiation, we observed PECAM-positive cells
(a marker of mature endothelial cells) with vessel-like structures
and beating a-actinin-positive cardiomyocytes (Figures 4A
and 4B). Intracellular recordings from the beating areas demon-
strated both atrial- (Figure 4C, upper) and ventricular-like
(Figure 4C, lower) cardiac action potentials. Chronotropic
regulation was found to be intact (Figure 4D), indicating the
presence of functional cardiomyocytes.
Previous reports have demonstrated the in vitro generation of
GCs from murine ESCs (Geijsen et al., 2004; Hu¨bner et al., 2003).
To further verify the pluripotency of 1F iPS, we attempted to
differentiate 1F iPS into GCs in vitro. Putative GC cultures
showed meiotic competence as demonstrated by expression
of Sycp3 protein (Figures 5A and 5B) and were FACS sorted
for GFP-positive (GFP+) or GFP-negative (GFP) cells represen-
tative of early and late postmigratory stages, respectively. Cell
fractions were analyzed using quantitative real-time PCR. The
GC character of in vitro differentiated 1F iPS was shown by the
upregulation of the specific markers Blimp1, Stella, Fragilis,
and Oct4 (Figure 5C). Importantly, in vitro differentiated cells
showed expression of Gdf9, an oocyte-specific marker,
suggesting that 1F iPS, although male, could differentiate into
oogonia-like cells as has been shown for ESCs (Hu¨bner et al.,
2003). These results demonstrate that 1F iPS can develop
even in vitro into GCs. The capacity of 1F iPS to differentiate
into lineage-committed cell populations of different germ layers
validates their pluripotent status.
1F iPS Cells Have an In Vivo Developmental Potential
Similar to Embryonic Stem Cells
To investigate the in vivo developmental potential of 1F iPS,
we performed teratoma formation and chimeras-contribution
assays. First, we determined that 1F iPS were capable of forming
teratomas upon subcutaneous inoculation into nude mice. The
teratomas contained tissues of all three germ layers including
neural rosette (ectoderm), cuboidal epithelium (endoderm), and
muscle (mesoderm) (Figures 6A and S5B). These data reveal
that 1F iPS possess multilineage potential in vivo.Cell 136, 411–419, February 6, 2009 ª2009 Elsevier Inc. 413
Figure 2. Characterization of 1F iPS
(A) RT-PCR analysis of pluripotency marker
expression in 1F iPS clones (C2, C3, and C4) and
ESCs (positive control), as well as NSCs (negative
control). Primers are specific for transcripts from
the respective endogenous locus. b-actin was
used as loading control.
(B) Quantitative PCR analysis of endogenous
expression of the four factors in 1F iPS clones
(C2, C3, and C4). RNA levels were determined by
quantitative real-time PCR using primers specific
for endogenous transcripts. Endogenous relative
expression levels of 1F iPS on day 3 (whole popu-
lation) and passage 5 (clones 2, 3, and 4) were
compared with those in ESCs. Transcript levels
were normalized to b-actin levels. Shown are the
averages with standard deviations of three inde-
pendent experiments.
(C) Analysis of the DNA methylation pattern of the
Oct4, Sox2, and Nanog promoters in NSCs and
NSC 1F, as well as in 1F iPS (clones 4 and 2), 2F
iPS cells (clone F-4), and ESCs. The red fragments
indicate methylated CpG dinucleotides, whereas
the blue fragments indicate unmethylated CpG
dinucleotides. Missing values are represented in
gray color.
(D and E) Scatter plots of the global gene expres-
sion patterns comparing 1F iPS (clone 2) with
ESCs (D) and 1F iPS (clone 2) with NSCs (E) by
cDNA microarrays. Black lines indicate 2-fold
changes in gene expression levels. Up- and down-
regulated genes in 1F iPS compared with ESCs or
NSCs are shown in blue or red, respectively. The
positions of the pluripotency genes Oct4, Nanog,
Sox2, c-Myc, Klf4, and Lin28 are shown in green.414 Cell 136, 411–419, February 6, 2009 ª2009 Elsevier Inc.DISCUSSION
This study has several implications. (1) Oct4 alone can induce
pluripotency in mouse adult NSCs. 1F iPS could be differenti-
ated into lineage-committed populations including GCs and
germline transmission. (2) iPS cells can be generated without
the oncogenic factors c-Myc and Klf4. Since reactivation of
the c-Myc virus may cause tumor development (Okita et al.,
2007), iPS cells have been generated without infection of the
c-Myc oncogene (Huangfu et al., 2008; Nakagawa et al., 2008;
Wernig et al., 2008). However, Klf4, the remaining oncogenic
factor, might cause tumor formation in offspring. (3) Reducing
the number of factors decreases the chance of retroviral inser-
tional mutagenesis. Analysis of previously described iPS cells
revealed up to 20 retroviral integrations for all four factors (Aoi
et al., 2008; Wernig et al., 2007). In this study, we demonstrate
that 1F iPS contain five integrations of only the Oct4 transgene
(Figure S3). (4) The starting cell population of NSCs, which
endogenously express Sox2, c-Myc, and Klf4 as well as AP
and SSEA-1, are a unique source for studying the mechanismsTo further assess their developmental potential, 1F iPS were
microinjected into mouse blastocysts (Table S1). After transfer
of the injected blastocysts into pseudopregnant recipients, we
observed by means of Oct4-GFP expression chimeric embryo
and germline contribution to the genital ridge of a 13 day post-
coitum (dpc) embryo (Figure 6B). Histological analysis revealed
that 1F iPS contributed to the development of various organs,
as shown by b-galactosidase staining (Figure 6C). We further-
more obtained two adult chimeras from 1F iPS (clone 2) as
determined by coat color and PCR genotyping for the pres-
ence of the GFP allele, the lacZ allele, and the pMX-Oct4
transgene (Figures 6D and 6E, Table S1). In addition, we
observed Oct4-GFP expression in the gonads of adult
chimeras, which clearly demonstrates germline contribution
(Figure 6F). Chimeric mice were mated in order to verify germ-
line transmission and two pups obtained thereof showed deri-
vation from 1F iPS, as revealed by genotyping for Oct4-GFP
and viral Oct4 transgene (Figure 6G). All these data dem-
onstrate that 1F iPS in vivo possess developmental potential
comparable to ESCs.
of iPS cell generation since they can be reprogrammed by one,
two, three, or four factors.
Strikingly, Oct4 alone is sufficient to induce pluripotency in
NSCs, which demonstrates its crucial role in the process of
reprogramming and supports our hypothesis that NSCs repre-
sent an intermediate state between differentiated and pluripo-
Figure 3. Differentiation of 1F iPS into NSCs
(A) RT-PCR analysis showing expression of NSC
marker genes from NSC 1F. b-actin was used as
loading control.
(B) Morphology (upper left) and Nestin expression
(upper right) of NSC 1F (passage 20). NSC 1F differ-
entiated into neurons (Tuj1), oligodendrocytes (O4),
and astrocytes (GFAP). Nuclei were counterstained
with DAPI (blue). Scale bars, 100 mm.
(C) Karyotype of NSC 1F. Metaphase spreads of
undifferentiated NSC 1F with a normal set of
40 mouse chromosomes are shown.
(D) Scatter plot of the global gene expression
comparing donor NSCs with NSC 1F by cDNA mi-
croarrays. Black lines indicate 2-fold changes in
gene expression levels. Up- and downregulated
genes in NSC 1F cells compared with NSCs are
shown in blue or red, respectively.
tent cells. 1F iPS have the pluripotency
to differentiate into all three germ layers,
as demonstrated by in vitro and in vivo
analysis. They can give rise to multipoten-
tial NSCs, cardiomyocytes with cardiac
action potential and chronotropic regula-
tion, and GCs as well as germline trans-
mission. This study sheds light on the
mechanisms involved in reprogramming
somatic cells to a pluripotent state. Future studies will show
whether other sources of neural stem or progenitor cell popula-
tions such as mouse or human bone marrow-derived mesen-
chymal stem cells (Hermann et al., 2004; Lee et al., 2003; Fu
et al., 2008) or dental pulp can be reprogrammed to iPS cells
and whether expression of Oct4 can be induced by nonretroviralCell 136, 411–41Figure 4. Differentiation of 1F iPS into Cardi-
omyocytes
In vitro differentiation of endothelial cell and cardi-
omyocytes through formation of embryoid bodies
(EBs). (A) Clustered PECAM-positive (left, red)
endothelial cells and (B) a-actinin-positive (right,
red) cross-striated cardiomyocytes are shown.
Nuclei were counterstained with Hoechst dye
(blue). Scale bar, 50 mm.
(C) Atrial- (upper) and ventricular- (lower) like action
potentials recorded from cardiomyocytes within
a 7+11 EB.
(D) Frequency of beating is enhanced by isoprena-
line (ISO, 0.1 mM) and slowed down to a complete
halt by the additional application of charbachol
(CCh, 10 mM). The CCh effect could be reversed
by washout (bottom inserts: original traces from
time points 1–4). Horizontal dashed lines indicate
0 mV lines.9, February 6, 2009 ª2009 Elsevier Inc. 415
means (Okita et al., 2008; Stadtfeld et al., 2008), a prerequisite
for the generation of iPS cells of therapeutic value.
EXPERIMENTAL PROCEDURES
Derivation of Adult NSCs and NSC 1F
Adult NSCs were isolated directly from the whole brain of OG2/Rosa26 trans-
genic mice and NSC 1F derived from 1F iPS. These cells were cultured in
neural expansion medium as previously described (Conti et al., 2005; Kim
et al., 2008).
Generation of 1F iPS
The pMX-based retroviral vector encoding the mouse cDNA of Oct4 (Takaha-
shi and Yamanaka, 2006) was cotransfected with packaging-defective helper
plasmids into 293 cells using Fugene 6 transfection reagent (Roche). Forty-
eight hours later, virus supernatants were collected as previously described
(Zaehres and Daley, 2006). NSCs derived from OG2/Rosa26 transgenic mice
were seeded at a density of 5 3 104 cells per 6-well plate and incubated
with virus-containing supernatants for Oct4 supplemented with 6 mg/ml prot-
amine sulfate (Sigma) for 24 hr. Transduction efficiencies were calculated
with pMX-GFP control virus. Cells were replated in fresh neural expansion
Figure 5. Characterization of 1F iPS In Vitro Differentiated GCs by
Immunohistochemistry for SYCP3 and Gene Expression Analysis
(A) Sycp3 accumulates in the nucleolar regions of putative germ cell (GC)
nuclei (arrowheads) and subsequently forms fibers (arrows), indicative of pre-
leptotene stage of prophase I.
(B) Organization of Sycp3 fibers in pachytene stage GCs. Note that entry of
meiosis is accompanied by a decrease of Oct4-GFP expression. Insert depicts
a higher magnification of a stained cell.
(C) Gene expression analysis of FACS-sorted cell populations of in vitro
derived GCs. GFP-positive cells (green) demonstrate upregulation of germ-
specific markers and represent cells of an early postmigratory stage. GFP
cells (orange) depict cells of a later stage of meiotic prophase I (B), character-
ized by a 2-fold higher Sycp3 expression when compared to the GFP+ subpop-
ulation. Scale bars, 10 mm. Transcript levels were normalized to b-actin levels.
Shown are the average values with standard deviations of three independent
experiments.416 Cell 136, 411–419, February 6, 2009 ª2009 Elsevier Inc.medium. Three days after infection, the cells were further subcultured on
irradiated MEFs in ESC medium containing LIF without any further selection.
Oct4-GFP-positive colonies were mechanically isolated, and individual cells
were dissociated and subsequently replated onto MEFs. iPS cells and ESCs
were grown on irradiated MEFs and in ESC medium (DMEM supplemented
with 15% FBS, nonessential amino acids, L-glutamine, penicillin/strepto-
mycin, b-mercaptoethanol, and 1000 U/ml leukemia inhibitory factor [LIF]).
The colonies were isolated for expansion.
qRT-PCR Analysis
Total RNA was extracted from cells using the MiniRNeasy Kit (QIAGEN GmbH;
http://www.qiagen.com) according to the manufacturer’s instructions.
Complementary DNA synthesis was performed with the High Capacity cDNA
Archive Kit (Applied Biosystems GmbH; http://www.appliedbiosystems.com)
following the manufacturer’s instructions with a downscaled reaction volume
of 20 ml. Transcript levels were determined using the ABI PRISM Sequence
Detection System 7900HT (Applied BioSystems) and the ready-to-use 50-
nuclease Assays-on-Demand. For each real-time amplification, the template
was equivalent to 5 ng of total RNA. Measurements were performed in tripli-
cate; a reverse-transcription-negative blank of each sample and a no-template
blank served as negative controls. Amplification curves and gene expression
were normalized to the housekeeping gene bAct, used as an internal standard.
Primers and probes are listed in the Supplemental Experimental Procedures.
SSEA-1 and AP Staining
SSEA-1 and AP staining was performed with the ES Cell Characterization Kit
(Chemicon) according to the manufacturer’s protocol.
Teratoma Formation
iPS cells and NSCs (1.53 106 cells/mouse) were injected subcutaneously into
the dorsal flank of nude mice. Four weeks after the injection, teratomas that
had formed were fixed overnight in 4% PFA and embedded in paraffin.
Sections were stained with hematoxylin and eosin dyes.
Chimera Formation
Four- to five-week-old female mice (B6C3F1) were induced to superovulation
(7.5 I.U. PMSG administration followed, 48 hr after, by 7.5 I.U. hCG administra-
tion via intraperitoneal injection) and mated with CD1. Blastocysts were
collected at day 3.5 after vaginal plug check and flushed in FHM medium con-
taining 0.1% PVP. Blasocysts were then extensively washed in FHM medium
and cultured in KSOM medium 0.2% BSA (KSOM-BSA) in the incubator (37C,
5% CO2 in air) until iPS cell injection.
Forty to fifty iPS colonies were selected and picked under a stereomicro-
scope based on the colony shape and morphology, washed in PBS, and
then transferred into a drop of 0.05% Trypsin in order to obtain a single cell
suspension. Single cells were then transferred into the micromanipulation
chamber in a drop of FHM medium 0.1% PVP 0.2% BSA. Groups of 12 to
15 cells were injected into each single blastocyst. Injected embryos were
then transferred into a drop of KSOM-BSA and cultured overnight at 37C
5% CO2 in air. The following day chimeric blastocysts were transplanted
into 2.5 dpc pseudopregnant CD1 recipient females.
Genotyping of iPS Cells and Chimeras
Genotyping was performed on genomic DNA isolated from iPS cells, ESCs,
and NSCs and on mouse tails, lysed by digestion at 55C in extraction buffer
(100 mM EDTA, 50 mM TRIS-HCl, 100 mM NaCl, 1% SDS, and 1.0 mg/ml
proteinase K). DNA was precipitated by adding isopropanol, washed twice
in 70% ethanol (v/v), and resuspended in TE (pH 8.0). After proteinase K inac-
tivation at 75C for 15 min, PCR was carried out with the following conditions:
94C 30 s (1 cycle); 94C 10 s, 57C 30 s, 72C 30 s (40 cycles); 72C 5 min.
Primer Sequences for Viral-Specific qRT–PCR, Genotyping,
and In Vitro Differentiation
Quantitative real-time PCR, genotyping of iPS cells, and in vitro differentiation
were performed using the primers as described (Kim et al., 2008).
Microarray Experiments
The gene expression profiles were obtained from ESC, 2F iPS, 1F iPS, NSC, and NSC
1F using the Mouse Genome 430 2.0 GeneChip arrays (Affymetrix). In the case of the
ESC, NSC, and two samples of the 2F iPS, we used our previous data sets (Kim et al.,
2008). In the case of an additional 2F iPS and triplicates of 1F iPS and NSC 1F, we
performed new microarrays. Briefly, 1m total RNA was subjected to probe preparation
andcRNA washybridized. Arrays werescannedusing anAffymetrixGCS3000device
and images were analyzed using the GCOS software. Normalization was calculated
with RMA algorithm (Irizarry et al., 2003) implemented in R-Bioconductor.
Characterization of NSC 1F Cells
NSC 1F cells were characterized by RT-PCR, karyotyping, in vitro differentia-
tion, and immunocytochemistry. Additional experimental details are available
in the Supplemental Experimental Procedures.
Figure 6. In Vivo Developmental Potential of 1F iPS
(A) Teratomas of 1F iPS (clone 2) contain all three embry-
onic germ layers: neural rosettes (ectoderm), epithelium
(endoderm), and muscle (mesoderm). Hematoxylin and
eosin-stained sections of teratomas derived in a nude
mouse host from 1F iPS (clone 2) after 4 weeks are shown.
Scale bars, 100 mm.
(B) Germline contribution of 1F iPS in chimeric embryos.
A whole-mount 13.5 dpc chimeric embryo was stained
with X-gal solution (left) and the fetal gonad was examined
for expression of Oct4-GFP (middle) using a fluorescence
microscope and control (right).
(C) Histological analysis of contribution of 1F iPS (clone 2)
in whole chimeric embryo (left) to stomach, intervertebral,
salivary glands, pancreas, metaphors, and upper lip.
(D) Chimeric mouse generated by 1F iPS (clone 2). The red
arrow indicates the chimerism originating from 1F iPS.
(E) PCR genotyping of chimeras derived from 1F iPS
(clone 2). PCR analysis was performed to genotype
chimeric males mated with CD1 females and demon-
strates the presence of GFP (top panel), lacZ allele (middle
panel), and pMX-Oct4 transgene (bottom panel).
(F) Germline contribution of 1F iPS in adult chimera
gonads. Oct4-GFP-positive cells from 1F iPS in tescular
tubules are shown.
(G) Germline transmission of 1F iPS, as judged from Oct4-
GFP expression and the presence of the Oct4 viral trans-
gene in two pups of the F1 generation.
Cardiomyocyte Differentiation of 1F iPS
EBs were generated from 1F iPS with the hanging drop
method for 2 days and subsequent culturing for another
3 days in DMEM + 20% FCS (Invitrogen) (Kolossov
et al., 1998). Differentiated EBs were fixed with 4%
paraformaldehyde and stained with antibodies against
a-sarcomeric-actinin (1:400, Sigma), PECAM (1:800,
PharMingen), and appropriate Cy3- or Cy5-conjugated
secondary antibodies (1:400-1:1000, Dianova). Nuclei
were stained with Hoechst dye (blue). Samples were
imaged using a Zeiss AxioImager microscope equipped
with an ApoTome and AxioCam MRm; images were
acquired with the Zeiss software AxioVision. For RT-
PCR, Oct4-GFP cells were isolated by FACS analysis
and used for in vitro differentiation of EBs in hanging
drops in ESC medium without LIF. After 3 days, EBs
were plated onto gelatine-coated 4-well dishes for an
additional 10 days. PCR was performed for 35 cycles
for all marker genes.
Action potential recordings were performed with sharp
electrodes (50–100 MU, filled with 3M KCl) impaled into
beating areas of EBs and a BA-03X amplifier (NPI electronic) at 1 kHz sampling
rate. Chronotropic regulation of cardiomyocytes was tested by applying first
Isoprenaline (0.1 mM) and subsequently carbachol (10 mM). Beating frequency
was calculated from beat to beat intervals with a 5 s running average. All phys-
iological recordings were performed at 36C ± 1C. Recording solution
(in mM): NaCl 140, KCl 5.4, CaCl2 2, MgCl2 1, glucose 10, HEPES 10, pH 7.4.
In Vitro Derivation of GCs
In vitro derivation of GCs from 1F iPS was performed according to Hu¨bner et al.
(2003), Hu¨bner et al. (2006), and our unpublished data. Putative GC cultures
were FACS sorted for GFP+ and GFP cells. Cell fractions were analyzed using
quantitative real-time PCR for GC markers.
Immunohistochemistry for SYCP3 was performed using the spreading tech-
nique described in Peters et al. (1997). Primary anti-SYCP3 (1:500; Abcam)Cell 136, 411–419, February 6, 2009 ª2009 Elsevier Inc. 417
was incubated overnight on slides at room temperature. After washing in
blocking solution, secondary fluorescent antibody (1:1000; Alexa 568; Molec-
ular Probes) was incubated for 1 hr at room temperature and slides were
mounted in DAPI containing mounting medium (Vectashield; Vector Laborato-
ries Inc.).
Southern Blot Analysis
BamHI digested genomic DNA from 4F iPS, 2F (OK) iPS, 1F iPS, and ESC was
separated on a 0.8% agarose gel and transferred to Biodyne B nylon
membrane (PALL Life Sciences). DNA was hybridized with a 32P-labeled
fragment of Oct4 (PstI/HindIII fragment of MX-mOct4) using the DecaLabel
DNA Labeling Kit (Fermentas). Labeled Lambda HindIII digested DNA served
as a marker.
Methylation Analysis
Genomic DNA sodium bisulfite conversion was performed using EZ-96 DNA
Methylation Kit (Zymo Research, Orange County, CA). The manufacturer’s
protocol was followed using 1 mg of genomic DNA and the alternative conver-
sion protocol (a two temperature DNA denaturation).
Sequenom’s MassARRAY platform was used to perform quantitative meth-
ylation analysis. This system utilizes matrix-assisted laser desorption ionization
time-of-flight (MALDI-TOF) mass spectrometry in combination with RNA base-
specific cleavage (MassCLEAVE). A detectable pattern is then analyzed
for methylation status. PCR primers were designed using EpiDESIGNER
(http://www.epidesigner.com). When it was feasible, amplicons were designed
to cover CpG islands in the same region as the 50UTR. For each reverse primer
an additional T7 promoter tag for in vivo transcription was added, as well as
a 10 mer tag on the forward primer to adjust for melting temperature differences.
The MassCLEAVE biochemistry was performed as previously described (Ehrich
et al., 2005). Mass spectra were acquired using a MassARRAY Compact
MALDI-TOF (Sequenom, San Diego, CA) and spectra’s methylation ratios
were generated by the Epityper software v1.0 (Sequenom).
ACCESSION NUMBERS
The microarray data are available from the GEO (Gene Expression Omnibus)
website under accession number GSE12499.
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